Matrix Stiffness Governs Fibroblasts’ Regulation of Gingival Immune Homeostasis
Advanced Materials · 2026-03 · 38 (15)
DOI: 10.1002/adma.202520717 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 08.02.2026. Verfasst von Hardik Makkar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center For Innovation & Precision Dentistry, University of Pennsylvania, Philadelphia, USA. Hauptthemen laut MEDLINE: Gingiva, Fibroblasts, Extracellular Matrix, Homeostasis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, National Institute of General Medical Sciences (NIGMS), NIGMS NIH HHS.
Abstract (Originalsprache)
Periodontal disease is characterized by inflamed gingival tissues and degradation of the gingival extracellular matrix (ECM), yet the role of mechanical cues remains poorly understood. Gingival ECM in periodontal disease showed reduced fibrillar collagen compared to healthy samples. We hypothesized that ECM softening in periodontal disease contributes to inflammation by dysregulating gingival fibroblasts (GFs). A mechanically tunable hydrogel model of the gingival ECM was developed to investigate the mechano‐immune crosstalk. Stiff and soft collagen‐alginate hydrogels matched the rheological properties of healthy and diseased gingival biopsies respectively. Human donor GFs encapsulated in these stiff hydrogels showed significantly suppressed toll‐like receptor‐mediated inflammatory responses compared to those in soft hydrogels. The non‐canonical NFκB pathway and epigenetic nuclear organization directed stiffness‐dependent inflammatory responses of GFs. The direct impact of mechanical cues on immune responses was investigated ex vivo by co‐culture of donor‐derived human GFs with myeloid cells and in human gingival explants. Myeloid progenitors co‐cultured with GFs in stiff hydrogels differentiated into immunomodulatory dendritic cells. Ex vivo crosslinking of human gingival tissue increased stiffness and reduced the production of inflammatory cytokines. Gingival mechano‐immune regulation offers a novel approach to biomaterial‐based treatments for periodontitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center For Innovation & Precision Dentistry, University of Pennsylvania, Philadelphia, USA.
- Department of Preventive and Restorative Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, USA.
- Department of Bioengineering, School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, USA.
- Department of Materials Science and Engineering, School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, USA.
- Department of Periodontics, School of Dental Medicine, University of Pennsylvania, Philadelphia, USA.
- Center For Engineering Mechanobiology, University of Pennsylvania, Philadelphia, USA.
ORCID-Profile: Kyle H Vining
Förderung
- NIDCR NIH HHS
- National Institute of General Medical Sciences (NIGMS)
- NIGMS NIH HHS
- NIH Office of the Director
- Graduate Research Fellowship from the National Science Foundation
- National Institute of Dental and Craniofacial Research
Zitieren
APA
Makkar, H., Tran, N., Chen, Y. C., Ko, K. I., Wells, R. G., & Vining, K. H. (2026). Matrix Stiffness Governs Fibroblasts’ Regulation of Gingival Immune Homeostasis. Advanced Materials, 38(15). https://doi.org/10.1002/adma.202520717
Vancouver
Makkar H, Tran N, Chen YC, Ko KI, Wells RG, Vining KH. Matrix Stiffness Governs Fibroblasts’ Regulation of Gingival Immune Homeostasis. Advanced Materials. 2026;38(15). doi:10.1002/adma.202520717
BibTeX
@article{Makkar2026,
author = {Makkar, Hardik and Tran, Nghi and Chen, Yu-Chang and Ko, Kang I and Wells, Rebecca G and Vining, Kyle H},
title = {Matrix Stiffness Governs Fibroblasts’ Regulation of Gingival Immune Homeostasis},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {15},
doi = {10.1002/adma.202520717}
}
EUVIMED